Aarti Pharmalabs Ltd. - Research Center
543748 AARTIPHARM Group (B) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 23 | |
|---|---|
| Sales | 714.28 |
| Operating profit | 150.55 |
| Interest | 7.85 |
| Gross profit | 147.56 |
| EPS (Rs) | 9.87 |
Half yearly
results in details
| Sep ' 23 | |
|---|---|
| Other income | 4.86 |
| Stock adjustment | -25.40 |
| Raw material | 390.52 |
| Power and fuel | - |
| Employee expenses | 61.37 |
| Excise | - |
| Admin and selling expenses | - |
| Research and development expenses | - |
| Expenses capitalised | - |
| Other expenses | 137.24 |
| Provisions made | - |
| Depreciation | 31.76 |
| Taxation | 26.36 |
| Net profit / loss | 89.44 |
| Extra ordinary item | - |
| Prior year adjustments | - |
| Equity capital | 45.31 |
| Equity dividend rate | - |
| Agg.of non-prom. shares (Lacs) | - |
| Agg.of non promotoholding (%) | - |
| OPM (%) | 21.08 |
| GPM (%) | 20.52 |
| NPM (%) | 12.44 |
Mutual Fund Selector
Find the fund that is right for you
© 2023 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis